SEC Form D · filed September 29, 2022
ELIXIRGEN THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Thomas K. White · Baltimore, MDDirectorHiroaki C. Kobayashi · Baltimore, MDDirectorMinoru S. Ko · Baltimore, MDExec · DirectorAkihiro C. Ko · Baltimore, MDExec · Director · PromoterShauna K. Callahan · Baltimore, MDDirectorMaiko Katadae · Baltimore, MDDirectorOla Soderquist · Needham, MAExec · Director · PromoterTyson Hunt · Columbia, MODirectorEdward Raha · Ponte Vedra Beach, FLExec · DirectorAndrew Sharp · Columbia, MODirectorJudson Ball · Columbia, MODirectorNatalia Pintus · Cleveland, OHExec · Director · PromoterRiley Chaney · Fresno, CAExec · DirectorHelena Foulkes · NEW YORK, NYDirectorJack Sarno · NEW YORK, NYDirectorDamien Hooper-Campbell · NEW YORK, NYDirectorMaiko Katadae · Baltimore, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗